Botanical species · safety record

Rumex patientia

The EFSA Compendium of Botanicals holds 11 constituent measurements and 3 adverse-effect records for Rumex patientia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rumex patientia L.

11Constituent measurements
3Safety records
7Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Emodin2
  • Tannins2
  • Anthraquinones1
  • Chrysophanol1
  • Furan derivatives1
  • Gallic acid1
  • Isoflavones1
  • Lignans1
  • Naphthalene derivatives1

Plant parts

  • Seed5
  • Roots and other underground parts4
  • Aerial part of plants3
  • Unspecified2

Preparations

  • Solvent extraction13

Effect types

  • Hepatotoxicity1
  • Nephrotoxicity1
  • Pulmonary and cardiac1

Target tissues

  • Liver1
  • Lung1
  • Urogenital: kidneys1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
ChrysophanolSeedSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
EmodinRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
EmodinSeedSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
AnthraquinonesAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Furan derivativesRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Gallic acidRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
IsoflavonesAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
LignansUnspecifiedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Naphthalene derivativesAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
TanninsUnspecifiedUnspecifiedNo resolvable identifier
TanninsRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverSeedSolvent extractionRat (as animal)Chronic/long term toxicityResolve DOI
NephrotoxicityUrogenital: kidneysSeedSolvent extractionRat (as animal)Chronic/long term toxicityResolve DOI
Pulmonary and cardiacLungSeedSolvent extractionRat (as animal)Chronic/long term toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yuan, Y., Chen, W.-S., Zheng, S.-Q., Yang, G.-J., Zhang, W.-D., Zhang, H.-M. Studies on chemical constituents in root of Rumex patientia L.. Zhongguo zhongyao zazhi, 2001, vol. 26, no. 4, p. 257-258.
  2. Schlemmer, F., Gentner, O. Pharmaceutical-chemical investigations on Rumex alpinus L. and Rumex patientia L. Archiv der pharmazie und berichte der deutschen pharmazeutischen gesellschaft, 1940, p. 252-283.
  3. Guinot, Pauline., Roge, Aline., Gargadennec, Annick., Garcia, Michel., Dupont, Daniel., Lecoeur, Edwige., Candelier, Laurent., Andary, Claude. Dyeing plants screening: an approach to combine past heritage and present development. Coloration Technology, 2006, p. 93-101.
  4. Zeng, Yong., Luo, Jian-Jun., Li, Chong. Chemical constituents from aerial part of Rumex patientia .. Zhong yao cai = zhongyaocai = journal of chinese medicinal materials, 2013, vol. 36, no. 1, p. 57-60.
  5. Gao, Liming., Wei, Xiaomei., Zheng, Shangzhen., Shen, Xuwei., Su, Yaozeng. Studies on chemical constituents of Rumex patientia. Zhongcaoyao, 2002, p. 207-209.
  6. Demirezer, LO., Kuruuzum-Uz, A., Bergere, I., Schiewe, HJ., Zeeck, A. The structures of antioxidant and cytotoxic agents from natural source: anthraquinones and tannins from roots of Rumex patientia . Phytochemistry, 2001, vol. 58, no. 8, p. 1213-1217. DOI
  7. Islam, Rabigul., Mamat, Yultuz., Ismayil, Ilyar., Yan, Ming., Kadir, Mahsutjan., Abdugheny, Abdujilil., Rapkat, Haximjan., Niyaz, Mardan., Ali, Yusupjan., Abay, Sirapil. Toxicity of Anthraquinones: Differential Effects of Rumex Seed Extracts on Rat Organ Weights and Biochemical and Haematological Parameters. PHYTOTHERAPY RESEARCH, 2015, vol. 29, no. 5, p. 777-784. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue